Epithalon Results Timeline
What the standard Epithalon research protocol looks like phase by phase, over a typical 20 days; 1–2 courses per year cycle. This is the escalation schedule from our full dosing protocol, presented as a timeline rather than a table.
Quick Facts
FREQUENCYOnce daily for 20 consecutive days
CYCLE LENGTH20 days; 1–2 courses per year
DOSE RANGE5 mg/day (fixed dose)
ROUTESubcutaneous injection
Phase-by-Phase Timeline
Loading / Titration
Days 1–10
Target dose: 5 mg
Maintenance
Days 11–20
Target dose: 5 mg
This timeline reflects the structure of the standard Epithalon research protocol documented on this site — it is not a guarantee of individual outcomes, and timelines vary between research subjects. All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.